scispace - formally typeset
S

Soo Y. Ko

Researcher at Novartis

Publications -  28
Citations -  608

Soo Y. Ko is an academic researcher from Novartis. The author has contributed to research in topics: Dihydroxylation & Diol. The author has an hindex of 13, co-authored 28 publications receiving 595 citations. Previous affiliations of Soo Y. Ko include Samsung & Ewha Womans University.

Papers
More filters
Journal ArticleDOI

Modification of Cyclosporin A (CS): Generation of an enolate at the sarcosine residue and reactions with electrophiles

TL;DR: In this paper, strong bases (lithium diisopropylamide (LDA) or BuLi) convert cyclosporin A (CS) to hexalithio derivative containing a Li alkoxide, four Li azaenolate, and one Li enolate units.
Journal ArticleDOI

Thiocyclosporins: Preparation, Solution and Crystal Structure, and Immunosuppressive Activity

TL;DR: In this paper, the reaction of cyclosporin A with Lawesson's reagent under different conditions yields various thiocyclosporins, in which carbonyl O-atoms and/or the hydroxy O-atom of the MeBmt residue are replaced by an S-atom.
Journal ArticleDOI

2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N- methylamide (SDZ NKT 343), a Potent Human NK1 Tachykinin Receptor Antagonist with Good Oral Analgesic Activity in Chronic Pain Models

TL;DR: A lead compound which had sub-micromolar affinity for the rabbit NK1 receptor but negligible affinity for rat NK1 receptors, 3a, was discovered by directed screening and proved to be a potent orally active analgesic in guinea pig models of chronic inflammatory and neuropathic pain.
Journal ArticleDOI

Synthetic applications of the cyclic iminocarbonate rearrangement: enantioselective syntheses of chloramphenicol and 4-epi-cytoxazone

TL;DR: Chloramphenicol and 4-epi-cytoxazone have been enantioselectively synthesized using the asymmetric dihydroxylation and the cyclic iminocarbonate rearrangement as key steps as discussed by the authors.